Dr. Wolchok on Weighing Risk and Benefit of Nivolumab/Ipilimumab Combo in Melanoma

Jedd D. Wolchok, MD, PhD
Published: Tuesday, Apr 04, 2017


Jedd D. Wolchok, MD, PhD, chief, Melanoma and Immunotherapeutics Service, Memorial Sloan Kettering Cancer Center, discusses weighing the overall survival (OS) benefit with the increased risk of toxicities seen with the combination of nivolumab (Opdivo) and ipilimumab (Yervoy) in treatment-naïve patients with advanced melanoma, during the AACR Annual Meeting.

Deciding whether to use this combination requires physicians to have a full discussion of all of the data with their patients, including the OS, response rates, and toxicities, Wolchok says. A patient's comorbidities and expectations also need to be taken into account, he adds.

This combination represents an opportunity to weigh risk and benefit on an individual patient basis, he says.

Jedd D. Wolchok, MD, PhD, chief, Melanoma and Immunotherapeutics Service, Memorial Sloan Kettering Cancer Center, discusses weighing the overall survival (OS) benefit with the increased risk of toxicities seen with the combination of nivolumab (Opdivo) and ipilimumab (Yervoy) in treatment-naïve patients with advanced melanoma, during the AACR Annual Meeting.

Deciding whether to use this combination requires physicians to have a full discussion of all of the data with their patients, including the OS, response rates, and toxicities, Wolchok says. A patient's comorbidities and expectations also need to be taken into account, he adds.

This combination represents an opportunity to weigh risk and benefit on an individual patient basis, he says.

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Precision Medicine for Community Oncologists: Assessing the Role of Tumor-Testing Technologies in Cancer CareNov 30, 20181.0
35th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® Clinical Vignette SeriesJan 31, 20192.0
Publication Bottom Border
Border Publication
x